Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bifodan is a specialized contract development and manufacturing organization (CDMO) focused on providing innovative probiotic solutions for the global dietary supplement and healthcare markets. Based in Denmark and established in 1938, the company offers end-to-end services ranging from strain selection and formulation development to manufacturing and packaging of finished products. Their expertise includes the development of patented delivery systems such as the Bifodan Fast Melt powder, which improves consumer compliance and product stability. In 2019, Bifodan was acquired by Deerland Probiotics & Enzymes, and it now operates as part of the ADM (Archer Daniels Midland) Health & Wellness business unit. The company continues to serve a global client base, leveraging clinical research and high-quality manufacturing standards to deliver evidence-based probiotic products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bifodan.